Literature DB >> 24793436

Changes in body composition secondary to neoadjuvant chemotherapy for advanced esophageal cancer are related to the occurrence of postoperative complications after esophagectomy.

Satoshi Ida1, Masayuki Watanabe, Ryuichi Karashima, Yu Imamura, Takatsugu Ishimoto, Yoshifumi Baba, Shiro Iwagami, Yasuo Sakamoto, Yuji Miyamoto, Naoya Yoshida, Hideo Baba.   

Abstract

BACKGROUND: Although a survival benefit of neoadjuvant treatment for patients with esophageal cancer has been highlighted, the influence of neoadjuvant treatment on the nutritional status of patients with esophageal cancer is not well understood.
METHODS: Changes in body composition parameters were assessed in 30 patients who underwent neoadjuvant chemotherapy (NAC) comprising docetaxel, cisplatin, and 5-fluorouracil followed by esophagectomy from August 2009 to April 2013. Body composition was evaluated before and after NAC using multifrequency bioelectrical impedance analysis (InBody 720; Biospace, Tokyo, Japan). Postoperative complications were graded according to the Clavien-Dindo classification.
RESULTS: Twenty-three postoperative events occurred in 16 patients. A decrease in body protein was observed in 13 patients (43.3 %), while skeletal muscle (SM), body cell mass (BCM), and fat-free mass (FFM) declined in 11 patients (36.7 %) during NAC. Changes in these four parameters during chemotherapy significantly differed between patients with postoperative complications and those without: protein, -1.6 ± 0.9 versus +4.4 ± 2.1 kg (P = 0.01); SM, -1.3 ± 1.1 versus +4.7 ± 2.4 kg (P = 0.02); BCM, -2.4 ± 1.6 versus +3.8 ± 2.2 kg (P = 0.03); and FFM, -1.4 ± 1.4 versus +4.3 ± 2.3 kg (P = 0.04).
CONCLUSIONS: Changes in body composition parameters are possible predictive markers of postoperative complications after esophagectomy after NAC. Further analysis is needed to clarify whether nutritional intervention improves such parameters and thus contributes to reduced postoperative morbidity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24793436     DOI: 10.1245/s10434-014-3737-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  22 in total

1.  Postoperative Changes in Body Composition After Pancreaticoduodenectomy Using Multifrequency Bioelectrical Impedance Analysis.

Authors:  Manabu Mikamori; Atsushi Miyamoto; Tadafumi Asaoka; Sakae Maeda; Naoki Hama; Kazuyoshi Yamamoto; Motohiro Hirao; Masataka Ikeda; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori; Shoji Nakamori
Journal:  J Gastrointest Surg       Date:  2015-12-21       Impact factor: 3.452

Review 2.  Recent progress in perioperative management of patients undergoing esophagectomy for esophageal cancer.

Authors:  Masayuki Watanabe; Akihiko Okamura; Tasuku Toihata; Kotaro Yamashita; Masami Yuda; Masaru Hayami; Ian Fukudome; Yu Imamura; Shinji Mine
Journal:  Esophagus       Date:  2018-04-25       Impact factor: 4.230

Review 3.  Perioperative body composition changes in the multimodal treatment of gastrointestinal cancer.

Authors:  Toru Aoyama
Journal:  Surg Today       Date:  2019-04-26       Impact factor: 2.549

Review 4.  Body Composition and Anti-Neoplastic Treatment in Adult and Older Subjects - A Systematic Review.

Authors:  S Gérard; D Bréchemier; A Lefort; S Lozano; G Abellan Van Kan; T Filleron; L Mourey; C Bernard-Marty; M E Rougé-Bugat; V Soler; B Vellas; M Cesari; Y Rolland; L Balardy
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

5.  Bioelectrical Impedance Analysis for the Assessment of Sarcopenia in Patients with Cancer: A Systematic Review.

Authors:  Gabriel F P Aleixo; Shlomit S Shachar; Kirsten A Nyrop; Hyman B Muss; Claudio L Battaglini; Grant R Williams
Journal:  Oncologist       Date:  2019-11-12

6.  Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer.

Authors:  Marta Sandini; Manuel Patino; Cristina R Ferrone; Carlos A Alvarez-Pérez; Kim C Honselmann; Salvatore Paiella; Matteo Catania; Luca Riva; Giorgia Tedesco; Raffaella Casolino; Alessandra Auriemma; Maria C Salandini; Giulia Carrara; Giulia Cristel; Anna Damascelli; Davide Ippolito; Mirko D'Onofrio; Keith D Lillemoe; Claudio Bassi; Marco Braga; Luca Gianotti; Dushyant Sahani; Carlos Fernández-Del Castillo
Journal:  JAMA Surg       Date:  2018-09-01       Impact factor: 14.766

Review 7.  Cachexia in patients with oesophageal cancer.

Authors:  Poorna Anandavadivelan; Pernilla Lagergren
Journal:  Nat Rev Clin Oncol       Date:  2015-11-17       Impact factor: 66.675

8.  Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer.

Authors:  Dietmar Tamandl; Matthias Paireder; Reza Asari; Pascal A Baltzer; Sebastian F Schoppmann; Ahmed Ba-Ssalamah
Journal:  Eur Radiol       Date:  2015-09-03       Impact factor: 5.315

9.  Neoadjuvant Chemoradiotherapy for Patients with cT3/Nearly T4 Esophageal Cancer: Is Sarcopenia Correlated with Postoperative Complications and Prognosis?

Authors:  Hiroshi Saeki; Yuichiro Nakashima; Kensuke Kudou; Shun Sasaki; Tomoko Jogo; Kosuke Hirose; Keitaro Edahiro; Shotaro Korehisa; Daisuke Taniguchi; Ryota Nakanishi; Nobuhide Kubo; Koji Ando; Akira Kabashima; Eiji Oki; Yoshihiko Maehara
Journal:  World J Surg       Date:  2018-09       Impact factor: 3.352

10.  A Walk-and-Eat Intervention Improves Outcomes for Patients With Esophageal Cancer Undergoing Neoadjuvant Chemoradiotherapy.

Authors:  Yu-Juan Xu; Jason Chia-Hsien Cheng; Jang-Ming Lee; Pei-Ming Huang; Guan-Hua Huang; Cheryl Chia-Hui Chen
Journal:  Oncologist       Date:  2015-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.